Literature DB >> 20736112

Snoring and obstructive sleep apnea.

Seckin O Ulualp1.   

Abstract

Obstructive sleep apnea (OSA) may be associated with myriad clinical consequences such as increased risk of systemic hypertension, coronary vascular disease, congestive heart failure, cerebrovascular disease, glucose intolerance, impotence, obesity, pulmonary hypertension, gastroesophageal reflux, and impaired concentration. Nonetheless, OSA remains undiagnosed in 82% of men and 93% of women with the condition. Early identification and treatment of OSA provides significant relief for individuals, prevents complications of OSA, and reduces overall health care costs. Better understanding of the pathogenesis, risk factors, diagnosis, and treatment of OSA has the potential to improve early recognition of OSA and prevention of adverse effects on the individual and society. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20736112     DOI: 10.1016/j.mcna.2010.05.002

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  4 in total

1.  Sleep disordered breathing (SDB) experiences associated with snoring in adult Nigerians.

Authors:  O A Sogebi; E A Oyewole; O O Olusoga-Peters
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

2.  Nocturnal snoring sound analysis in the diagnosis of obstructive sleep apnea in the Chinese Han population.

Authors:  Huajun Xu; Wei Song; Hongliang Yi; Limin Hou; Changheng Zhang; Bin Chen; Yuqin Chen; Shankai Yin
Journal:  Sleep Breath       Date:  2014-09-09       Impact factor: 2.816

3.  Flow Simulation in the Upper Respiratory Tract of Two Obstructive Sleep Apnea Patients with Successful and Failed Surgery.

Authors:  Jiacun Shao; Weiwei Yan; Yang Liu; Mingzhen Lu
Journal:  Comput Math Methods Med       Date:  2021-05-07       Impact factor: 2.238

4.  Risk factors of obstructive sleep apnea among Nigerian outpatients.

Authors:  Olusola Ayodele Sogebi; Adegboyega Ogunwale
Journal:  Braz J Otorhinolaryngol       Date:  2012-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.